120 related articles for article (PubMed ID: 3142093)
1. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.
Alving BM; Krishnamurti C; Liu YP; Lucas DL; Wright DG
Thromb Res; 1988 Jul; 51(2):175-85. PubMed ID: 3142093
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
4. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
6. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
7. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).
Oliver LJ; Keeton M; Wilson EL
Blood; 1989 Sep; 74(4):1321-7. PubMed ID: 2504306
[TBL] [Abstract][Full Text] [Related]
8. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
10. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
Krishnamurti C; Alving B
Rev Infect Dis; 1989; 11 Suppl 4():S843-6. PubMed ID: 2501855
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus.
Krishnamurti C; Wahl LM; Alving BM
Am J Trop Med Hyg; 1989 Jan; 40(1):102-7. PubMed ID: 2492775
[TBL] [Abstract][Full Text] [Related]
12. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1: identification, characterization and regulation by inflammatory mediators.
Arndt A; Murphy P; Hart DA
Biochim Biophys Acta; 1992 Feb; 1138(2):149-56. PubMed ID: 1371701
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
14. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
Tienari J; Alanko T; Lehtonen E; Saksela O
Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
[TBL] [Abstract][Full Text] [Related]
15. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
Rehemtulla A; Gates J; Hart DA
Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
[TBL] [Abstract][Full Text] [Related]
17. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
18. Production of protease inhibitors by postsurgical macrophages.
Fukasawa M; Campeau JD; Girgis W; Bryant SM; Rodgers KE; DiZerega GS
J Surg Res; 1989 Mar; 46(3):256-61. PubMed ID: 2493532
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
Niiya K; Sakuragawa N
Nihon Rinsho; 1992 Feb; 50(2):325-9. PubMed ID: 1319513
[TBL] [Abstract][Full Text] [Related]
20. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
